Vincerx Pharma Inc expected to post a loss of 61 cents a share - Earnings Preview

Vincerx Pharma

24/03/2023 13:46

* Vincerx Pharma Inc  VINC.OQ   VINC.O  is expected to show
no
change in quarterly revenue when it reports  results on March 27
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Vincerx Pharma Inc
is for
a loss of 61 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Vincerx
Pharma
Inc is $7.5​, above​ its last closing price of $0.90. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.64       -0.55      -0.80     Missed  -44.8
 Jun. 30 2022  -0.82       -0.79      -0.88     Missed  -10.7
 Mar. 31 2022  -0.72       -0.76      -0.79     Missed  -4.5​
 Dec. 31 2021  -0.87       -0.93      -0.31     Beat    66.7
 ​​Sep.        -0.86       -0.85      -1.39     Missed  -63.9
 30 2021                                                
 Jun. 30 2021              -0.37      -0.12     Beat    68​
 Mar. 31 2021  -0.32       -0.32      -0.46     Missed  -43.7
 This summary was machine generated March 24 at 13:46 GMT.  All
figures in US dollars  unless otherwise stated